Extended optical treatment for children with amblyopia in Europe: the EuPatch trial - Authors' reply.

Autor: Proudlock FA; Ulverscroft Eye Unit, School of Psychology and Vision Sciences, University of Leicester, Leicester, UK., Hisaund M; Ulverscroft Eye Unit, School of Psychology and Vision Sciences, University of Leicester, Leicester, UK., Papageorgiou E; General University Hospital of Larissa, Larissa, Greece., Manouchehrinia A; The Karolinska Neuroimmunology and Multiple Sclerosis Centre, Department of Clinical Neurosciences, Karolinska University Hospital, Stockholm, Sweden., Gottlob I; Ulverscroft Eye Unit, School of Psychology and Vision Sciences, University of Leicester, Leicester, UK; Department of Neurology, Cooper University Health Care, Cooper Medical School of Rowan University, Camden, NJ 08103, USA. Electronic address: ig15@le.ac.uk.
Jazyk: angličtina
Zdroj: Lancet (London, England) [Lancet] 2024 Dec 14; Vol. 404 (10470), pp. 2421-2422.
DOI: 10.1016/S0140-6736(24)02235-9
Databáze: MEDLINE